In vitro activity of thioridazine against mycobacteria

International Journal of Antimicrobial Agents

Volumn 34, Issue 2, 2009, Pages 190-191

  van Ingen, Jakko ^a,b   van der Laan, Tridia ^b   Amaral, Leonard ^c   Dekhuijzen, Richard ^a   Boeree, Martin J ^a   van Soolingen, Dick ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

THIORIDAZINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; IN VITRO STUDY; LETTER; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; THIORIDAZINE;

EID: 67349140657     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.02.015     Document Type: Letter

References (7)

1. Sohaskey C.D. Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol 190 (2008) 2981-2986
2. Ordway D., Viveiros M., Leandro C., Bettencourt R., Almeida J., Martins M., et al. Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 47 (2003) 917-922
3. Mitnick C.D., Shin S.S., Seung K.J., Rich M.L., Atwood S.S., Furin J.J., et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 359 (2008) 563-574
4. Jenkins P.A., Campbell I.A., Banks J., Gelder C.M., Prescott R.J., and Smith A.P. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in the treatment of opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 63 (2008) 627-634 [Erratum. Thorax 2008;63:844]
5. Griffith D.E., Aksamit T., Brown-Elliot B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007) 367-416
6. van Klingeren B., Dessens-Kroon M., van der Laan T., Kremer K., and van Soolingen D. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. J Clin Microbiol 45 (2007) 2662-2668
7. Glassman A.H., and Bigger Jr. J.T. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158 (2001) 1774-1782